今日早盘,荣昌生物股价出现大幅下跌,盘中一度下跌5.91%至18.07港元。该股成交活跃,成交金额超2亿港元,但并无重大利空消息曝光。
从最新财报数据来看,荣昌生物最近一期每股收益为-2.21港元,净利润也出现了亏损,但公司业务依然稳步发展。机构研究人员普遍看好该股长期前景。近期,多家机构进行了现场调研,就公司主要产品、研发进展等相关事项进行了解。
分析指出,荣昌生物作为生物技术类公司,股票波动较大、资金博弈明显是正常现象。今日的股价下跌或只是个别资金获利离场,或市场观望情绪使然,并无任何确切的利空因素。短期内,该股走势仍需继续关注。如果无重大利好利空事件发生,预计后市将呈现区间波动格局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.